Design, synthesis and structure-activity relationships of (indo-3-yl) heterocyclic derivatives as agonists of the CB1 receptor. Discovery of a clinical candidate.

Source:http://linkedlifedata.com/resource/pubmed/id/21411321

Bioorg. Med. Chem. Lett. 2011 Apr 15 21 8 2541-6

Download in:

View as

General Info

PMID
21411321